const flashcardsGroup13 = [
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A 70-year-old patient with heart failure and chronic kidney disease (GFR 25 mL/min) is prescribed digoxin 0.125 mg daily for atrial fibrillation rate control.",
    question: "What is the nurse's priority assessment related to this medication and the patient's comorbidities?",
    answer: `<h3>ANSWER:</h3>
<p>Assess for signs and symptoms of <strong>digoxin toxicity</strong>.</p>
<ul>
  <li>Older adults and patients with impaired renal function are at significantly increased risk for digoxin toxicity due to decreased drug excretion.</li>
  <li>Digoxin has a narrow therapeutic index (0.5-2.0 ng/mL).</li>
  <li>Monitor heart rate (apical pulse for 1 full minute) before administration; hold if <60 bpm.</li>
  <li>Assess potassium levels (hypokalemia increases risk of toxicity).</li>
  <li>Assess for early signs of toxicity: anorexia, nausea, vomiting.</li>
  <li>Assess for late signs: bradycardia, arrhythmias, visual disturbances (yellow/green halos), confusion.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking warfarin (Coumadin) for atrial fibrillation reports taking over-the-counter ibuprofen for knee pain for the past three days. Their INR today is 4.5.",
    question: "What is the nurse's primary concern, and what immediate actions should be taken?",
    answer: `<h3>ANSWER:</h3>
<p>The primary concern is the significantly increased <strong>risk of bleeding</strong> due to the synergistic effect of warfarin and NSAIDs, indicated by the supratherapeutic INR.</p>
<ul>
  <li>NSAIDs inhibit platelet function and can cause gastric irritation/bleeding.</li>
  <li>Warfarin inhibits Vitamin K-dependent clotting factors.</li>
  <li>Combining them greatly elevates bleeding risk.</li>
</ul>
<p><strong>PRIORITY INTERVENTIONS:</strong></p>
<ol>
  <li><strong>Hold</strong> the next dose of warfarin.</li>
  <li>Notify the healthcare provider immediately about the elevated INR and NSAID use.</li>
  <li>Assess the patient thoroughly for any signs of active bleeding (gums, urine, stool, bruising, vital sign changes).</li>
  <li>Prepare for potential administration of Vitamin K (phytonadione) or other reversal agents (PCC) as ordered.</li>
  <li>Educate the patient on avoiding NSAIDs while taking warfarin and using acetaminophen for pain relief instead.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with hypertension is prescribed lisinopril. During patient education, the patient asks why they need regular blood tests while on this medication.",
    question: "What essential laboratory values must be monitored for a patient taking an ACE inhibitor like lisinopril, and why?",
    answer: `<h3>ANSWER:</h3>
<p>Serum <strong>potassium</strong> and <strong>renal function tests (BUN, Creatinine)</strong> must be monitored.</p>
<ul>
  <li>ACE inhibitors block the action of aldosterone, which normally promotes potassium excretion. This can lead to <strong>hyperkalemia</strong>, especially in patients with renal impairment or those taking potassium supplements/sparing diuretics.</li>
  <li>ACE inhibitors can potentially cause <strong>renal dysfunction</strong> or worsen pre-existing kidney disease, requiring monitoring of BUN and creatinine.</li>
  <li>Baseline and periodic monitoring are crucial for safety.</li>
  <li>Hyperkalemia can cause dangerous cardiac arrhythmias.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A 55-year-old patient is started on atorvastatin for hyperlipidemia. The patient calls the clinic complaining of diffuse muscle aches and weakness for the past two days.",
    question: "What potentially serious adverse effect might this patient be experiencing, and what is the priority nursing action?",
    answer: `<h3>ANSWER:</h3>
<p>The patient may be experiencing <strong>myopathy</strong>, potentially progressing to <strong>rhabdomyolysis</strong>, a serious adverse effect of statin medications.</p>
<ul>
  <li>Myopathy involves muscle pain, soreness, tenderness, or weakness.</li>
  <li>Rhabdomyolysis is the breakdown of muscle fibers, releasing myoglobin into the bloodstream, which can cause acute kidney injury.</li>
  <li>Creatine Kinase (CK) levels are typically elevated.</li>
</ul>
<p><strong>PRIORITY ACTION:</strong></p>
<ol>
  <li>Instruct the patient to <strong>stop taking the atorvastatin immediately</strong>.</li>
  <li>Advise the patient to come in for evaluation and laboratory testing (including CK levels) promptly.</li>
  <li>Notify the healthcare provider of the patient's symptoms.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient is receiving intravenous vancomycin for a severe MRSA infection. During the infusion, the nurse observes flushing of the patient's face, neck, and upper torso, along with itching and mild hypotension.",
    question: "What is this reaction likely called, and what is the immediate nursing intervention?",
    answer: `<h3>ANSWER:</h3>
<p>This reaction is likely <strong>"Red Man Syndrome,"</strong> an infusion-related reaction associated with rapid vancomycin administration, not a true allergic reaction.</p>
<ul>
  <li>It is caused by histamine release.</li>
  <li>Symptoms include flushing, erythema, pruritus, and sometimes hypotension or chest discomfort.</li>
</ul>
<p><strong>PRIORITY INTERVENTIONS:</strong></p>
<ol>
  <li><strong>Stop</strong> the vancomycin infusion immediately.</li>
  <li>Assess vital signs (especially blood pressure).</li>
  <li>Notify the healthcare provider.</li>
  <li>Administer antihistamines (e.g., diphenhydramine) as ordered.</li>
  <li>Once symptoms resolve, the infusion may be restarted at a significantly slower rate (e.g., over 90-120 minutes) per provider order.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with type 2 diabetes and hypertension is prescribed metoprolol. The patient reports feeling shaky and sweaty but denies palpitations or tachycardia, which usually signal hypoglycemia for them.",
    question: "What is the most likely explanation for the patient's altered perception of hypoglycemic symptoms?",
    answer: `<h3>ANSWER:</h3>
<p>Metoprolol, a beta-blocker, can <strong>mask the adrenergic symptoms</strong> of hypoglycemia.</p>
<ul>
  <li>Beta-blockers inhibit the sympathetic nervous system response (tachycardia, tremors, palpitations) typically associated with low blood sugar.</li>
  <li>Sweating (a cholinergic symptom) may still occur.</li>
  <li>Patients with diabetes taking beta-blockers must be educated to recognize other hypoglycemic signs (sweating, confusion, dizziness, blurred vision) and monitor blood glucose levels closely.</li>
  <li>This poses a significant safety risk as patients may not recognize hypoglycemia until it becomes severe.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with peptic ulcer disease is prescribed omeprazole (Prilosec). The patient asks when the best time to take this medication is.",
    question: "What is the optimal timing for administering a proton pump inhibitor (PPI) like omeprazole, and why?",
    answer: `<h3>ANSWER:</h3>
<p>PPIs like omeprazole should typically be administered <strong>30-60 minutes before the first meal of the day</strong> (usually breakfast).</p>
<ul>
  <li>PPIs work by irreversibly blocking the H+/K+ ATPase (proton pump) in active gastric parietal cells.</li>
  <li>The number of active proton pumps is highest after a period of fasting, in anticipation of food intake.</li>
  <li>Taking the PPI before a meal allows peak drug concentration to coincide with the maximal activation of proton pumps, maximizing acid suppression.</li>
  <li>Most PPI capsules/tablets should be swallowed whole, not crushed or chewed.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "An older adult patient residing in a long-term care facility is prescribed famotidine (Pepcid) for GERD. The nurse notes the patient has become increasingly confused and agitated over the past few days.",
    question: "What potential adverse effect of H₂ Receptor Antagonists (H₂RAs) should the nurse consider, particularly in this patient population?",
    answer: `<h3>ANSWER:</h3>
<p>H₂ Receptor Antagonists, especially in older adults or those with renal/hepatic impairment, can cause <strong>CNS side effects</strong>, including <strong>confusion, agitation, delirium, or lethargy</strong>.</p>
<ul>
  <li>These effects are thought to be related to the drug crossing the blood-brain barrier.</li>
  <li>Famotidine generally has fewer CNS effects than older H₂RAs like cimetidine, but the risk still exists.</li>
  <li>The nurse should assess the patient's mental status, review other potential causes of confusion, and notify the provider to consider adjusting the dose or changing medication.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient is prescribed psyllium (Metamucil) for chronic constipation.",
    question: "What is the single most critical patient education point regarding the administration of bulk-forming laxatives like psyllium?",
    answer: `<h3>ANSWER:</h3>
<p>The patient <strong>MUST</strong> take psyllium with a <strong>full glass (at least 8 ounces or 240 mL) of water</strong> or other fluid.</p>
<ul>
  <li>Bulk-forming laxatives work by absorbing water into the intestine, increasing bulk and peristalsis.</li>
  <li>Insufficient fluid intake can cause the psyllium to swell in the throat or esophagus, leading to choking or obstruction.</li>
  <li>It can also cause bowel obstruction or fecal impaction if not taken with adequate fluid.</li>
  <li>Advise mixing the powder well and drinking it immediately, possibly followed by another glass of water.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient admitted with acute infectious diarrhea (fever 101.5°F, bloody stools) requests loperamide (Imodium) for symptom relief.",
    question: "Why is administering an antidiarrheal agent like loperamide potentially contraindicated in this patient?",
    answer: `<h3>ANSWER:</h3>
<p>Antidiarrheal agents like loperamide are generally contraindicated in suspected infectious diarrhea, especially if associated with fever or bloody stools.</p>
<ul>
  <li>These agents slow intestinal motility.</li>
  <li>Slowing transit time can <strong>prolong the presence of the infectious organism</strong> (e.g., C. difficile, Salmonella, Shigella) in the gut.</li>
  <li>This can worsen the infection, increase systemic absorption of toxins, and potentially lead to complications like toxic megacolon.</li>
  <li>Treatment should focus on hydration, electrolyte replacement, and identifying/treating the underlying cause (antibiotics if bacterial and indicated).</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient is receiving gentamicin IV for a serious gram-negative infection. The nurse is reviewing the patient's morning labs, which include BUN 35 mg/dL and Creatinine 1.8 mg/dL (both elevated from baseline).",
    question: "What major toxicities are associated with aminoglycosides like gentamicin, and what action should the nurse take based on these labs?",
    answer: `<h3>ANSWER:</h3>
<p>Aminoglycosides (e.g., gentamicin, tobramycin) are associated with significant <strong>Nephrotoxicity</strong> and <strong>Ototoxicity</strong>.</p>
<ul>
  <li>The elevated BUN and Creatinine indicate potential kidney injury (nephrotoxicity).</li>
  <li>Ototoxicity can manifest as hearing loss (cochlear damage) or balance problems (vestibular damage) and may be irreversible.</li>
</ul>
<p><strong>PRIORITY ACTION:</strong></p>
<ol>
  <li><strong>Hold</strong> the next dose of gentamicin.</li>
  <li>Notify the healthcare provider immediately of the elevated renal function tests.</li>
  <li>Assess the patient for signs of ototoxicity (changes in hearing, tinnitus, dizziness, vertigo).</li>
  <li>Ensure adequate patient hydration (unless contraindicated).</li>
  <li>Monitor drug peak and trough levels as ordered.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient is prescribed ciprofloxacin for a complicated urinary tract infection. The patient also takes calcium carbonate (Tums) daily for heartburn.",
    question: "What important administration instruction must the nurse provide regarding these two medications?",
    answer: `<h3>ANSWER:</h3>
<p>The patient must <strong>separate the administration</strong> of ciprofloxacin and calcium carbonate by at least <strong>2 hours before or 6 hours after</strong> the ciprofloxacin dose.</p>
<ul>
  <li>Fluoroquinolones like ciprofloxacin can chelate (bind) with cations like calcium, magnesium, aluminum (found in antacids), iron, and zinc.</li>
  <li>Concurrent administration significantly reduces the absorption and bioavailability of the fluoroquinolone, potentially leading to treatment failure.</li>
  <li>This interaction also applies to dairy products and multivitamins containing minerals.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A 25-year-old female patient is prescribed doxycycline for Lyme disease.",
    question: "What are two critical patient education points the nurse must emphasize for this patient taking a tetracycline antibiotic?",
    answer: `<h3>ANSWER:</h3>
<p>Two critical education points are <strong>photosensitivity</strong> and <strong>contraindication in pregnancy/young children</strong>.</p>
<ul>
  <li><strong>Photosensitivity:</strong> Tetracyclines can cause exaggerated sunburn reactions. Advise strict sun avoidance, use of high-SPF sunscreen, and protective clothing during therapy and for several days after.</li>
  <li><strong>Contraindication in Pregnancy/Children <8:</strong> Tetracyclines bind to calcium in developing teeth, causing permanent yellow/brown discoloration. They are contraindicated during pregnancy and in children under 8 years old. Ensure the patient is not pregnant and understands the risk.</li>
  <li>Also advise separating doses from dairy products, antacids, and iron supplements.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with a known Sulfa allergy develops a UTI, and the provider inadvertently prescribes trimethoprim/sulfamethoxazole (Bactrim). The patient develops a widespread blistering rash and fever after the first dose.",
    question: "What severe adverse reaction should the nurse suspect, and what is the immediate priority?",
    answer: `<h3>ANSWER:</h3>
<p>The nurse should suspect <strong>Stevens-Johnson Syndrome (SJS)</strong>, a rare but life-threatening hypersensitivity reaction associated with sulfonamides and other drugs.</p>
<ul>
  <li>SJS involves severe blistering of the skin and mucous membranes.</li>
  <li>It requires immediate medical attention.</li>
</ul>
<p><strong>PRIORITY INTERVENTIONS:</strong></p>
<ol>
  <li><strong>Stop</strong> the trimethoprim/sulfamethoxazole immediately.</li>
  <li>Assess the patient's airway, breathing, circulation, and extent of the rash/blistering.</li>
  <li>Notify the healthcare provider urgently.</li>
  <li>Provide supportive care (fluids, pain management, wound care) often in a specialized unit (burn center).</li>
  <li>Document the reaction clearly as a severe allergy.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient being treated for C. difficile infection with oral metronidazole (Flagyl) complains of nausea and asks if they can have a glass of wine with dinner to help settle their stomach.",
    question: "What specific, potentially severe reaction necessitates advising the patient against consuming alcohol while taking metronidazole?",
    answer: `<h3>ANSWER:</h3>
<p>Consuming alcohol while taking metronidazole can cause a <strong>Disulfiram-like reaction</strong>.</p>
<ul>
  <li>This reaction occurs because metronidazole inhibits the enzyme aldehyde dehydrogenase, leading to an accumulation of acetaldehyde when alcohol is consumed.</li>
  <li>Symptoms include severe nausea, vomiting, flushing, headache, tachycardia, and potentially hypotension.</li>
  <li>Patients must be educated to avoid <strong>ALL</strong> forms of alcohol (including mouthwash, cough syrups, some sauces) during therapy and for at least 3 days after completing the course.</li>
  <li>Nausea is a common side effect; taking metronidazole with food may help.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient undergoing treatment for tuberculosis (TB) with a multi-drug regimen including Rifampin expresses alarm that their urine and sweat have turned orange-red.",
    question: "How should the nurse respond to the patient's concern about the discoloration of body fluids?",
    answer: `<h3>ANSWER:</h3>
<p>Reassure the patient that the orange-red discoloration of urine, sweat, tears, and saliva is a <strong>harmless and expected side effect</strong> of Rifampin.</p>
<ul>
  <li>While not dangerous, it can be alarming if the patient is unprepared.</li>
  <li>Educate the patient that this effect will persist throughout treatment.</li>
  <li>Warn that soft contact lenses may become permanently stained.</li>
  <li>Emphasize the importance of continuing the medication as prescribed despite this side effect.</li>
  <li>Continue to monitor for hepatotoxicity (a serious risk with Rifampin and other TB drugs).</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient is prescribed Isoniazid (INH) as part of their multi-drug therapy for tuberculosis.",
    question: "What vitamin supplement is typically co-administered with Isoniazid, and why is it necessary?",
    answer: `<h3>ANSWER:</h3>
<p><strong>Pyridoxine (Vitamin B6)</strong> is typically co-administered with Isoniazid (INH).</p>
<ul>
  <li>Isoniazid can interfere with the metabolism of pyridoxine, leading to a deficiency.</li>
  <li>Pyridoxine deficiency can cause <strong>peripheral neuropathy</strong> (manifesting as numbness, tingling, or burning in the extremities).</li>
  <li>Co-administration of Vitamin B6 helps prevent this common and potentially debilitating side effect.</li>
  <li>Patients should also be monitored for signs of hepatotoxicity, another major risk with INH.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking Ethambutol for tuberculosis reports blurry vision and difficulty distinguishing between red and green colors.",
    question: "What adverse effect is specific to Ethambutol, and what nursing action is required?",
    answer: `<h3>ANSWER:</h3>
<p>Ethambutol can cause <strong>Optic Neuritis</strong>, an inflammation of the optic nerve.</p>
<ul>
  <li>Symptoms include decreased visual acuity, blurred vision, and changes in color perception (especially red-green discrimination).</li>
  <li>This effect is dose-related and potentially reversible if the drug is stopped promptly, but permanent vision loss can occur.</li>
</ul>
<p><strong>NURSING ACTION:</strong></p>
<ol>
  <li>Instruct the patient to <strong>stop taking Ethambutol immediately</strong>.</li>
  <li>Notify the healthcare provider urgently about the visual changes.</li>
  <li>Schedule an ophthalmologic examination.</li>
</ol>
<ul>
  <li>Baseline and regular visual acuity and color discrimination testing are essential during ethambutol therapy.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient hospitalized with severe sepsis and fungal bloodstream infection is started on intravenous Amphotericin B. Within 30 minutes of starting the infusion, the patient develops shaking chills, high fever (103°F), and nausea.",
    question: "What is the likely cause of these symptoms, and what nursing interventions can help manage this common reaction?",
    answer: `<h3>ANSWER:</h3>
<p>These symptoms are characteristic of an <strong>infusion-related reaction</strong> ("shake and bake") commonly associated with conventional Amphotericin B.</p>
<ul>
  <li>This reaction is caused by the release of pro-inflammatory cytokines.</li>
  <li>It is not an allergic reaction but can be severe.</li>
</ul>
<p><strong>NURSING INTERVENTIONS:</strong></p>
<ol>
  <li>Slow or temporarily stop the infusion (per protocol/order).</li>
  <li>Administer <strong>pre-medications</strong> as ordered before future infusions (e.g., acetaminophen, diphenhydramine, corticosteroids, meperidine for rigors).</li>
  <li>Monitor vital signs closely during infusion.</li>
  <li>Ensure adequate hydration.</li>
  <li>Use a test dose before the first therapeutic dose if ordered.</li>
</ol>
<ul>
  <li>Newer lipid formulations of Amphotericin B cause fewer infusion reactions but are more expensive. Intense monitoring for nephrotoxicity and electrolyte imbalances (K+, Mg++) remains crucial with all forms.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient is prescribed enoxaparin (Lovenox) 40 mg subcutaneous daily for DVT prophylaxis post-operatively.",
    question: "What is the primary advantage of using Low Molecular Weight Heparin (LMWH) like enoxaparin over Unfractionated Heparin (UFH) for prophylaxis, and what key patient teaching is required for self-administration?",
    answer: `<h3>ANSWER:</h3>
<p>The primary advantage of LMWH is its <strong>predictable anticoagulant response</strong>, allowing for fixed dosing <strong>without the need for routine laboratory monitoring</strong> (like aPTT for UFH infusions). It also has a longer half-life and lower risk of Heparin-Induced Thrombocytopenia (HIT).</p>
<ul>
  <li><strong>Key Patient Teaching for SubQ Injection:</strong>
    <ul>
      <li>Site selection (abdomen, avoiding ~2 inches around umbilicus; alternatively outer thigh).</li>
      <li>Rotate injection sites.</li>
      <li>Do <strong>NOT</strong> expel the air bubble in prefilled syringes (helps ensure full dose delivery).</li>
      <li>Pinch skin fold, insert needle at 90 degrees.</li>
      <li>Inject slowly.</li>
      <li>Do <strong>NOT</strong> rub the site after injection (increases bruising).</li>
      <li>Monitor for signs of bleeding.</li>
    </ul>
  </li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient stabilized on warfarin therapy for DVT has a new prescription for Amiodarone added for atrial fibrillation.",
    question: "What potential interaction exists between warfarin and amiodarone, and what adjustment is likely necessary?",
    answer: `<h3>ANSWER:</h3>
<p>Amiodarone significantly <strong>inhibits the metabolism of warfarin</strong>, leading to increased warfarin levels and a higher risk of bleeding.</p>
<ul>
  <li>This interaction can dramatically increase the INR.</li>
  <li>When initiating amiodarone in a patient on stable warfarin therapy, the warfarin dose typically needs to be substantially <strong>reduced</strong> (often by 25-50%).</li>
  <li>Close monitoring of INR is essential after starting amiodarone, with frequent dose adjustments needed until INR stabilizes in the therapeutic range.</li>
  <li>Educate the patient on increased bleeding risk and signs/symptoms to report.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with heart failure is prescribed furosemide (Lasix) 40 mg IV push. The patient complains of ringing in their ears during the rapid infusion.",
    question: "What adverse effect is associated with rapid IV administration of loop diuretics like furosemide, and how can it be prevented?",
    answer: `<h3>ANSWER:</h3>
<p>Rapid IV administration of loop diuretics, especially at high doses or in patients with renal impairment, can cause <strong>Ototoxicity</strong> (hearing loss or tinnitus).</p>
<ul>
  <li>This effect is usually transient but can sometimes be permanent.</li>
  <li>Prevention involves administering IV furosemide <strong>slowly</strong>, typically no faster than 4 mg/min for doses >120mg, or as per institutional policy (e.g., infuse 40 mg over 1-2 minutes).</li>
  <li>Monitor for changes in hearing during and after administration.</li>
  <li>Assess renal function, as impaired excretion increases risk.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with hypertension and heart failure is taking lisinopril, spironolactone, and consumes potassium-rich foods. Their serum potassium level is 6.2 mEq/L.",
    question: "What is the priority nursing concern, and what immediate actions are indicated?",
    answer: `<h3>ANSWER:</h3>
<p>The priority concern is severe <strong>hyperkalemia</strong>, which can lead to life-threatening cardiac dysrhythmias (e.g., peaked T waves, widened QRS, V-fib, asystole).</p>
<ul>
  <li>Both ACE inhibitors (lisinopril) and potassium-sparing diuretics (spironolactone) increase potassium levels. Combining them significantly elevates risk.</li>
  <li>High dietary potassium intake further contributes.</li>
</ul>
<p><strong>PRIORITY ACTIONS:</strong></p>
<ol>
  <li>Hold doses of lisinopril and spironolactone.</li>
  <li>Place the patient on continuous cardiac monitoring (ECG).</li>
  <li>Notify the healthcare provider immediately.</li>
  <li>Prepare to administer treatments to lower potassium as ordered (e.g., IV calcium gluconate for cardiac protection, IV insulin with dextrose, sodium polystyrene sulfonate, diuretics if renal function allows, dialysis).</li>
  <li>Restrict dietary potassium intake.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with stable angina uses sublingual nitroglycerin PRN for chest pain. They report experiencing a pounding headache shortly after taking a tablet.",
    question: "How should the nurse explain this common side effect of nitroglycerin?",
    answer: `<h3>ANSWER:</h3>
<p>Explain that <strong>headache</strong> is a common and expected side effect of nitroglycerin due to its <strong>vasodilating effect</strong>, particularly on cerebral blood vessels.</p>
<ul>
  <li>Nitroglycerin causes widespread vasodilation, which reduces cardiac preload and afterload, alleviating angina, but also dilates other vessels.</li>
  <li>The headache typically diminishes with continued use or can be managed with mild analgesics like acetaminophen (if approved by provider).</li>
  <li>Reassure the patient that this indicates the medication is working.</li>
  <li>Emphasize the importance of sitting or lying down when taking SL nitroglycerin to prevent dizziness or syncope due to potential hypotension.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A nurse is preparing to administer digoxin to a patient whose apical pulse is 54 bpm. The patient's serum digoxin level from this morning is 1.5 ng/mL.",
    question: "What is the appropriate nursing action?",
    answer: `<h3>ANSWER:</h3>
<p><strong>Hold the dose</strong> of digoxin and notify the healthcare provider.</p>
<ul>
  <li>Bradycardia (apical pulse <60 bpm in adults) is a key sign of potential digoxin toxicity or excessive effect, <strong>even if the serum level is within the "therapeutic" range</strong> (0.5-2.0 ng/mL).</li>
  <li>Clinical signs and symptoms (like bradycardia) take precedence over the lab value alone, especially since toxicity can occur even within the therapeutic range, particularly if hypokalemia is present.</li>
  <li>Document the heart rate and the held dose.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking amiodarone long-term for recurrent ventricular tachycardia complains of a persistent dry cough and shortness of breath on exertion.",
    question: "What serious, potentially life-threatening toxicity associated with amiodarone should the nurse suspect?",
    answer: `<h3>ANSWER:</h3>
<p>The nurse should suspect <strong>Pulmonary Toxicity</strong> (specifically pulmonary fibrosis or pneumonitis).</p>
<ul>
  <li>This is one of the most serious adverse effects of long-term amiodarone therapy.</li>
  <li>Symptoms can be insidious, including dry cough, dyspnea, chest pain, and low-grade fever.</li>
  <li>It requires prompt evaluation, including pulmonary function tests (PFTs) and potentially chest imaging.</li>
  <li>If confirmed, amiodarone typically needs to be discontinued. Close monitoring of respiratory status is essential.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with Alzheimer's disease is prescribed donepezil (Aricept). The caregiver reports the patient has experienced increased nausea and decreased appetite since starting the medication.",
    question: "What class of medication is donepezil, and what common side effect profile explains these symptoms? What nursing intervention can help manage this?",
    answer: `<h3>ANSWER:</h3>
<p>Donepezil is a <strong>Cholinesterase Inhibitor</strong> used to increase acetylcholine levels in the brain for mild-to-moderate Alzheimer's disease.</p>
<ul>
  <li>Common side effects are primarily <strong>gastrointestinal</strong> due to increased cholinergic activity systemically. These include nausea, vomiting, diarrhea, anorexia, and potential weight loss.</li>
  <li>Bradycardia is another key cholinergic side effect to monitor.</li>
  <li>Nursing intervention: Advise administering the medication <strong>with food</strong> to help minimize GI upset. Monitor weight and nutritional intake. Titrating the dose slowly upon initiation can also improve tolerability.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking phenytoin (Dilantin) 100 mg TID for seizures has a serum phenytoin level of 8 mcg/mL (Therapeutic range 10-20 mcg/mL). The patient reports experiencing breakthrough seizure activity.",
    question: "Based on the serum level and patient report, what is the most likely therapeutic issue?",
    answer: `<h3>ANSWER:</h3>
<p>The patient's serum phenytoin level is <strong>subtherapeutic</strong>, which is likely contributing to the breakthrough seizure activity.</p>
<ul>
  <li>Phenytoin requires maintenance within a narrow therapeutic range (10-20 mcg/mL) for optimal seizure control.</li>
  <li>Levels below 10 mcg/mL are often insufficient to prevent seizures.</li>
  <li>Factors contributing to low levels could include non-adherence, inadequate dosage, drug interactions affecting metabolism, or changes in absorption.</li>
  <li>The provider needs to be notified to consider a dosage adjustment based on the level and clinical presentation.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking phenytoin long-term comes to the dental clinic. The dental hygienist notes significant overgrowth of the patient's gums.",
    question: "What is this side effect called, and what preventative measure should the nurse emphasize for patients taking phenytoin?",
    answer: `<h3>ANSWER:</h3>
<p>This side effect is called <strong>Gingival Hyperplasia</strong>.</p>
<ul>
  <li>It is a common long-term side effect of phenytoin therapy, characterized by swelling, tenderness, and overgrowth of gum tissue.</li>
  <li>While not usually dangerous, it can affect oral hygiene, comfort, and aesthetics.</li>
</ul>
<p><strong>PREVENTATIVE MEASURE:</strong></p>
<ul>
  <li>Emphasize the critical importance of <strong>meticulous oral hygiene</strong>, including regular brushing, flossing, and routine dental check-ups (every 3-6 months).</li>
  <li>Good oral care can help minimize the severity of gingival hyperplasia.</li>
  <li>Folic acid supplementation may also be helpful, but consult provider.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient prescribed carbamazepine (Tegretol) for seizures calls the clinic reporting a sore throat, fever, and new bruises on their arms and legs.",
    question: "What potentially life-threatening adverse effect of carbamazepine could these symptoms indicate, and what is the priority nursing action?",
    answer: `<h3>ANSWER:</h3>
<p>These symptoms could indicate <strong>Bone Marrow Suppression</strong> (including leukopenia, thrombocytopenia, anemia, or rarely, aplastic anemia/agranulocytosis), a serious adverse effect associated with carbamazepine (<strong>Black Box Warning</strong>).</p>
<ul>
  <li>Sore throat and fever may signal infection due to low white blood cells (leukopenia/agranulocytosis).</li>
  <li>Bruising may signal low platelets (thrombocytopenia).</li>
</ul>
<p><strong>PRIORITY ACTION:</strong></p>
<ol>
  <li>Instruct the patient to <strong>stop taking carbamazepine immediately</strong>.</li>
  <li>Advise the patient to seek <strong>immediate medical evaluation</strong>, including a Complete Blood Count (CBC).</li>
  <li>Notify the prescribing provider urgently.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A female patient of childbearing potential with a seizure disorder is taking valproic acid (Depakote).",
    question: "What critical safety information regarding valproic acid must the nurse provide to this patient?",
    answer: `<h3>ANSWER:</h3>
<p>Valproic acid is highly <strong>teratogenic</strong> and carries a <strong>Black Box Warning</strong> regarding the risk of major congenital malformations, particularly <strong>neural tube defects</strong> (like spina bifida), if taken during pregnancy.</p>
<ul>
  <li>Women of childbearing potential MUST be counseled on the risks and the absolute necessity of using <strong>effective contraception</strong> during therapy.</li>
  <li>Folic acid supplementation is recommended for all women of childbearing potential taking AEDs, but it does not eliminate the teratogenic risk of valproic acid.</li>
  <li>Discuss alternative AED options with the provider if pregnancy is planned.</li>
  <li>Also carries risks of hepatotoxicity and pancreatitis (BBWs).</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient is starting lamotrigine (Lamictal) as an add-on therapy for seizures. The titration schedule increases the dose weekly. The patient calls after 10 days reporting a new skin rash.",
    question: "What is the major concern with a rash developing during lamotrigine therapy, especially early in treatment or with rapid titration? What should the nurse instruct the patient to do?",
    answer: `<h3>ANSWER:</h3>
<p>The major concern is the potential for a serious, life-threatening rash, including <strong>Stevens-Johnson Syndrome (SJS)</strong> or <strong>Toxic Epidermal Necrolysis (TEN)</strong>. Lamotrigine carries a <strong>Black Box Warning</strong> for this risk.</p>
<ul>
  <li>The risk is highest during the initial 2-8 weeks of therapy, with rapid dose escalation, or when co-administered with valproic acid.</li>
  <li>Any rash occurring during lamotrigine therapy must be considered potentially serious until proven otherwise.</li>
</ul>
<p><strong>INSTRUCTION:</strong></p>
<ol>
  <li>Instruct the patient to <strong>stop taking lamotrigine immediately</strong>.</li>
  <li>Advise the patient to seek <strong>immediate medical evaluation</strong> (urgent care or emergency department).</li>
  <li>Notify the prescribing provider.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with Parkinson's disease taking Levodopa/Carbidopa (Sinemet) reports that their symptoms (tremor, rigidity) return and worsen about 30 minutes before their next scheduled dose is due.",
    question: "What phenomenon is this patient likely experiencing, and what potential medication adjustments might be considered?",
    answer: `<h3>ANSWER:</h3>
<p>The patient is likely experiencing the <strong>"wearing-off" phenomenon</strong>.</p>
<ul>
  <li>This occurs with long-term levodopa therapy, where the duration of benefit from each dose becomes shorter, leading to the re-emergence of Parkinson's motor symptoms before the next dose is due.</li>
  <li>It indicates fluctuating dopamine levels.</li>
</ul>
<p><strong>POTENTIAL ADJUSTMENTS</strong> (by provider):</p>
<ul>
  <li>Adjusting the dosing interval (giving doses closer together).</li>
  <li>Using a controlled-release (CR) formulation of levodopa/carbidopa.</li>
  <li>Adding other medications like a COMT inhibitor (e.g., entacapone) or an MAO-B inhibitor (e.g., rasagiline) to prolong levodopa's effect.</li>
  <li>Adding a dopamine agonist.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with Parkinson's disease taking pramipexole (Mirapex) reports suddenly falling asleep during conversations and while eating, without prior warning. Their spouse also reports the patient has recently started gambling excessively online.",
    question: "What two significant adverse effects associated with dopamine agonists like pramipexole are illustrated here?",
    answer: `<h3>ANSWER:</h3>
<p>The scenario illustrates two significant adverse effects of dopamine agonists:</p>
<ol>
  <li><strong>Somnolence and Sudden Sleep Onset ("Sleep Attacks"):</strong> Patients can experience excessive daytime sleepiness and fall asleep abruptly during activities, posing safety risks (e.g., driving).</li>
  <li><strong>Impulse Control Disorders:</strong> Dopamine agonists are strongly associated with the development of compulsive behaviors like pathological gambling, hypersexuality, compulsive shopping, or binge eating.</li>
</ol>
<ul>
  <li>Nurses must specifically screen for these behaviors and warn patients/families.</li>
  <li>Monitor BP for orthostatic hypotension as well.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "An older adult patient with Parkinson's disease and mild cognitive impairment is prescribed benztropine (Cogentin) for tremors. The patient becomes acutely confused and complains of dry mouth and difficulty urinating.",
    question: "Why is benztropine generally avoided in older adults, and what effects is this patient experiencing?",
    answer: `<h3>ANSWER:</h3>
<p>Benztropine is an <strong>anticholinergic</strong> medication generally avoided in older adults due to its high risk of causing significant <strong>anticholinergic side effects</strong>.</p>
<ul>
  <li>Anticholinergic drugs block acetylcholine, which is crucial for cognitive function (already compromised in this patient) and parasympathetic functions.</li>
  <li>The patient is experiencing classic anticholinergic effects:
    <ul>
      <li>Confusion/Cognitive Impairment (CNS effect)</li>
      <li>Dry Mouth (Peripheral effect)</li>
      <li>Urinary Retention (Peripheral effect)</li>
    </ul>
  </li>
  <li>Other potential effects include constipation, blurred vision, and tachycardia. These effects are particularly problematic and poorly tolerated in the elderly.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A 22-year-old patient started on fluoxetine (Prozac) for depression two weeks ago reports feeling \"more energy\" but states their mood is \"still really low\" and admits to having more frequent thoughts of suicide.",
    question: "What is the priority nursing concern based on this patient's report?",
    answer: `<h3>ANSWER:</h3>
<p>The priority concern is the <strong>increased risk of suicide</strong>, particularly in the early phases of antidepressant treatment (<strong>Black Box Warning</strong> for patients <25 years).</p>
<ul>
  <li>Antidepressants, especially SSRIs like fluoxetine, may increase energy levels before improving mood.</li>
  <li>This temporary increase in energy can provide patients with the capacity to act on pre-existing suicidal thoughts.</li>
  <li>Therapeutic effects on mood can take 2-6 weeks to become fully apparent.</li>
  <li>This patient requires immediate assessment for suicide risk, close monitoring, and potentially urgent intervention or consultation with the mental health team/provider.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking phenelzine (Nardil), an MAOI, for depression attends a party and eats aged cheese, cured sausage, and drinks red wine. They develop a severe occipital headache, stiff neck, sweating, and nausea/vomiting. Their blood pressure is 210/120 mmHg.",
    question: "What life-threatening adverse reaction is occurring, and what is the cause?",
    answer: `<h3>ANSWER:</h3>
<p>The patient is experiencing a <strong>Hypertensive Crisis</strong>.</p>
<ul>
  <li>This is caused by ingesting foods or beverages high in <strong>tyramine</strong> while taking a Monoamine Oxidase Inhibitor (MAOI).</li>
  <li>MAOIs prevent the breakdown of tyramine, an amino acid that can raise blood pressure. Accumulation of tyramine leads to a massive release of norepinephrine, causing severe vasoconstriction and potentially life-threatening hypertension.</li>
  <li>Foods high in tyramine include aged cheeses, cured/smoked meats, fermented foods, soy sauce, draft beer, and red wine.</li>
  <li>This is a medical emergency requiring immediate treatment to lower blood pressure.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient admitted to the surgical unit is taking Haloperidol (Haldol) PRN for agitation. The nurse observes the patient experiencing involuntary muscle spasms of the neck and face, with their eyes rolling upwards.",
    question: "What type of extrapyramidal symptom (EPS) is the patient likely experiencing, and what is the priority intervention?",
    answer: `<h3>ANSWER:</h3>
<p>The patient is likely experiencing an <strong>Acute Dystonic Reaction</strong>, a type of EPS common with typical antipsychotics like haloperidol.</p>
<ul>
  <li>Acute dystonia involves sudden, involuntary muscle contractions or spasms, often affecting the face, neck, back, or eyes (oculogyric crisis). It can be frightening and painful, and potentially life-threatening if airway muscles are involved (laryngospasm).</li>
</ul>
<p><strong>PRIORITY INTERVENTION:</strong></p>
<ol>
  <li>Ensure airway patency.</li>
  <li>Notify the provider immediately.</li>
  <li>Prepare to administer an <strong>anticholinergic medication like benztropine (Cogentin) or diphenhydramine (Benadryl)</strong> IM or IV as ordered, which usually provides rapid relief.</li>
  <li>Reassure the patient.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking olanzapine (Zyprexa), an atypical antipsychotic, has gained 25 lbs over the past 6 months. Their fasting blood glucose is 135 mg/dL, and their lipid profile shows elevated triglycerides.",
    question: "What cluster of adverse effects, common with atypical (second-generation) antipsychotics, do these findings represent? What monitoring is essential?",
    answer: `<h3>ANSWER:</h3>
<p>These findings represent <strong>Metabolic Syndrome</strong>, a significant cluster of adverse effects associated with many atypical antipsychotics (SGAs), particularly olanzapine and clozapine.</p>
<ul>
  <li>Metabolic Syndrome includes:
    <ul>
      <li>Weight gain (often significant)</li>
      <li>Hyperglycemia / New-onset or worsening Type 2 Diabetes</li>
      <li>Dyslipidemia (elevated triglycerides, decreased HDL)</li>
    </ul>
  </li>
  <li><strong>Essential Monitoring</strong> for patients on SGAs:
    <ul>
      <li>Baseline and regular monitoring of weight, BMI, waist circumference.</li>
      <li>Baseline and regular monitoring of fasting blood glucose or HgbA1c.</li>
      <li>Baseline and regular monitoring of lipid profile.</li>
    </ul>
  </li>
  <li>Promote healthy diet and exercise.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking clozapine (Clozaril) calls the clinic complaining of a sudden onset of fever, chills, and a severe sore throat.",
    question: "What potentially fatal adverse effect specific to clozapine must be suspected, and what immediate action is required?",
    answer: `<h3>ANSWER:</h3>
<p><strong>Agranulocytosis</strong>, a potentially fatal drop in absolute neutrophil count (ANC), must be suspected. Clozapine carries a <strong>Black Box Warning</strong> for this risk.</p>
<ul>
  <li>Symptoms like fever, sore throat, chills, or malaise can indicate a severe infection secondary to the lack of neutrophils.</li>
</ul>
<p><strong>IMMEDIATE ACTION:</strong></p>
<ol>
  <li>Instruct the patient to <strong>hold the clozapine dose</strong>.</li>
  <li>Instruct the patient to go immediately to a facility for a <strong>STAT Complete Blood Count (CBC) with differential</strong> to check the ANC.</li>
  <li>Notify the prescribing provider urgently.</li>
</ol>
<ul>
  <li>Clozapine requires mandatory enrollment in a REMS program with strict ANC monitoring before, during, and after therapy.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking a typical antipsychotic develops a high fever (104°F), severe \"lead pipe\" muscle rigidity, altered mental status (confusion), and autonomic instability (tachycardia, labile BP). Labs show a markedly elevated Creatine Kinase (CK).",
    question: "What medical emergency should the nurse recognize based on the FEVER mnemonic (Fever, Encephalopathy, Vitals unstable, Elevated enzymes, Rigidity)?",
    answer: `<h3>ANSWER:</h3>
<p>This presentation strongly indicates <strong>Neuroleptic Malignant Syndrome (NMS)</strong>.</p>
<ul>
  <li>NMS is a rare but potentially fatal reaction to antipsychotic medications (more common with typical/FGAs).</li>
  <li>Key features are captured by the <strong>FEVER</strong> mnemonic:
    <ul>
      <li><strong>F</strong>ever (high)</li>
      <li><strong>E</strong>ncephalopathy (altered mental status)</li>
      <li><strong>V</strong>itals unstable (autonomic dysfunction)</li>
      <li><strong>E</strong>levated enzymes (CK due to muscle rigidity/breakdown)</li>
      <li><strong>R</strong>igidity (severe, "lead pipe")</li>
    </ul>
  </li>
</ul>
<p><strong>PRIORITY ACTIONS:</strong></p>
<ol>
  <li><strong>Stop</strong> the antipsychotic medication immediately.</li>
  <li>Notify the provider urgently / Initiate emergency response.</li>
  <li>Implement supportive care (cooling measures, hydration, hemodynamic support).</li>
  <li>Prepare for potential administration of dantrolene or bromocriptine.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "An older adult patient admitted for pneumonia becomes acutely agitated and confused. The provider orders lorazepam (Ativan) 1 mg IV.",
    question: "What is the primary risk associated with administering benzodiazepines like lorazepam to older adults, and what precautions should the nurse implement?",
    answer: `<h3>ANSWER:</h3>
<p>The primary risk is excessive <strong>CNS depression</strong>, leading to sedation, drowsiness, confusion, ataxia, and an increased risk of <strong>falls</strong>. Older adults are more sensitive to the effects of benzodiazepines due to age-related changes in pharmacokinetics and pharmacodynamics.</p>
<ul>
  <li>Respiratory depression risk is also increased, especially if combined with other CNS depressants (e.g., opioids).</li>
</ul>
<p><strong>PRECAUTIONS:</strong></p>
<ol>
  <li>Administer the lowest effective dose.</li>
  <li>Monitor level of consciousness, respiratory rate, and oxygen saturation closely.</li>
  <li>Implement fall precautions (bed low, call light accessible, frequent monitoring, assist with ambulation).</li>
  <li>Assess for paradoxical agitation (increased excitement or restlessness).</li>
  <li>Avoid concurrent use with other CNS depressants if possible.</li>
</ol>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking lithium carbonate for bipolar disorder presents to the ED with coarse hand tremors, confusion, persistent nausea/vomiting, and slurred speech. Their last lithium level (drawn 2 days ago) was 1.1 mEq/L. They report starting ibuprofen for back pain yesterday.",
    question: "What condition should the nurse suspect, and what factor likely precipitated it?",
    answer: `<h3>ANSWER:</h3>
<p>The nurse should suspect <strong>Lithium Toxicity</strong>.</p>
<ul>
  <li>Symptoms described (coarse tremor, confusion, GI upset, ataxia/slurred speech) are consistent with moderate-to-severe toxicity (levels typically >1.5 mEq/L, but can occur at lower levels).</li>
  <li>The likely precipitating factor is the initiation of <strong>ibuprofen (an NSAID)</strong>. NSAIDs can decrease renal blood flow and reduce lithium excretion, leading to increased serum lithium levels and toxicity.</li>
  <li>Dehydration, low sodium intake, and thiazide diuretics can also increase lithium levels.</li>
  <li>Immediate interventions include stopping lithium and NSAIDs, checking serum lithium level, hydration, and supportive care; dialysis may be needed for severe toxicity.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient is prescribed polyethylene glycol (MiraLAX) for chronic constipation.",
    question: "What is the mechanism of action of osmotic laxatives like polyethylene glycol, and what is a key counseling point regarding its onset of action?",
    answer: `<h3>ANSWER:</h3>
<p>Polyethylene glycol is an osmotic laxative that works by <strong>drawing water into the lumen of the colon</strong>.</p>
<ul>
  <li>This increases stool water content, softening the stool and increasing stool volume, which stimulates peristalsis.</li>
  <li><strong>Key Counseling Point:</strong> Educate the patient that polyethylene glycol typically takes <strong>1 to 3 days (24-72 hours)</strong> to produce a bowel movement. It is not intended for rapid relief of constipation.</li>
  <li>Ensure adequate fluid intake is maintained. Generally considered safe for longer-term use compared to stimulant laxatives. Monitor for electrolyte imbalance with excessive use, though less common with PEG than other osmotics like magnesium citrate.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient taking multiple medications, including an SSRI (sertraline) and tramadol for pain, develops agitation, confusion, hyperreflexia, muscle rigidity, diaphoresis, and fever (102°F).",
    question: "What potentially life-threatening syndrome should the nurse suspect based on this combination of medications and symptoms?",
    answer: `<h3>ANSWER:</h3>
<p>The nurse should suspect <strong>Serotonin Syndrome</strong>.</p>
<ul>
  <li>This occurs when there is excessive serotonergic activity in the CNS, often due to combining medications that increase serotonin levels (e.g., SSRIs, SNRIs, MAOIs, TCAs, triptans, tramadol, St. John's Wort).</li>
  <li>Key features include:
    <ul>
      <li>Mental status changes (agitation, confusion)</li>
      <li>Autonomic instability (hyperthermia, tachycardia, diaphoresis, labile BP)</li>
      <li>Neuromuscular hyperactivity (tremor, hyperreflexia, clonus, rigidity)</li>
    </ul>
  </li>
  <li>This is a medical emergency requiring immediate discontinuation of serotonergic agents and supportive care. Cyproheptadine (serotonin antagonist) may be used in severe cases.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A nurse is teaching a patient about administering their new prescription for enoxaparin (Lovenox) subcutaneously at home.",
    question: "Which specific patient statement indicates a need for further teaching regarding LMWH injection technique?",
    answer: `<h3>ANSWER:</h3>
<p>Statements indicating a need for further teaching include:</p>
<ul>
  <li>"I should <strong>rub the site vigorously</strong> after injecting to help it absorb." (Incorrect: Rubbing increases bruising).</li>
  <li>"I need to <strong>squeeze out the little air bubble</strong> before I inject." (Incorrect: The air bubble in prefilled syringes should generally be injected to ensure the full dose is delivered and seal the track).</li>
  <li>"I can inject it into the muscle of my upper arm." (Incorrect: It is a subcutaneous injection, typically given in the abdomen or outer thigh).</li>
  <li>"I will use the same spot on my belly every day." (Incorrect: Sites should be rotated to prevent tissue damage/lipohypertrophy).</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with heart failure receiving IV furosemide develops muscle cramps, weakness, and demonstrates flattened T-waves on their ECG monitor.",
    question: "Which electrolyte imbalance is most likely responsible for these signs and symptoms?",
    answer: `<h3>ANSWER:</h3>
<p><strong>Hypokalemia</strong> (low serum potassium).</p>
<ul>
  <li>Loop diuretics like furosemide are potent diuretics that significantly increase the excretion of potassium, often leading to hypokalemia.</li>
  <li>Signs and symptoms of hypokalemia include muscle weakness, fatigue, cramps, constipation, and potentially dangerous cardiac arrhythmias (e.g., flattened T-waves, U-waves, premature ventricular contractions, ventricular tachycardia).</li>
  <li>Close monitoring of serum potassium levels is essential during loop diuretic therapy.</li>
  <li>Potassium supplementation may be required.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient with hypertension controlled on hydrochlorothiazide (HCTZ) reports increased frequency of gout attacks since starting the medication.",
    question: "What potential metabolic side effect of thiazide diuretics can exacerbate gout?",
    answer: `<h3>ANSWER:</h3>
<p>Thiazide diuretics like HCTZ can cause <strong>Hyperuricemia</strong> (increased serum uric acid levels).</p>
<ul>
  <li>They decrease the renal excretion of uric acid.</li>
  <li>Elevated uric acid levels can precipitate acute gout attacks in susceptible individuals.</li>
  <li>Monitor uric acid levels if indicated. Use cautiously in patients with a history of gout.</li>
  <li>Other metabolic effects include hyperglycemia, hypercalcemia, hypokalemia, hyponatremia, and hyperlipidemia.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient is prescribed a rivaroxaban (Xarelto), a direct oral anticoagulant (DOAC), for non-valvular atrial fibrillation. The patient asks if they need frequent blood tests like their friend who takes warfarin.",
    question: "What is the primary advantage of DOACs like rivaroxaban compared to warfarin regarding laboratory monitoring? What is a critical adherence point?",
    answer: `<h3>ANSWER:</h3>
<p>A primary advantage of DOACs (Factor Xa inhibitors like rivaroxaban, apixaban; Direct thrombin inhibitors like dabigatran) is that they have a predictable dose-response and generally <strong>do not require routine coagulation monitoring</strong> (like INR for warfarin).</p>
<ul>
  <li><strong>Critical Adherence Point:</strong> Due to their relatively short half-lives compared to warfarin, <strong>strict adherence</strong> to the prescribed dosing schedule is crucial. Missing even one dose can significantly reduce anticoagulant protection and increase thromboembolic risk. Emphasize the importance of taking the medication exactly as prescribed without missing doses.</li>
</ul>`
  },
  {
    category: "pharmacology",
    type: "Pharmacology",
    scenario: "A patient is receiving an IV infusion of regular insulin for diabetic ketoacidosis (DKA). The nurse notes the patient's serum potassium level has decreased from 4.5 mEq/L to 3.1 mEq/L since starting the infusion.",
    question: "What is the physiological reason for the decrease in serum potassium during insulin infusion therapy?",
    answer: `<h3>ANSWER:</h3>
<p>Insulin administration causes potassium to <strong>shift from the extracellular fluid (bloodstream) into the intracellular space</strong>.</p>
<ul>
  <li>Insulin promotes the uptake of glucose into cells, and it also activates the Na+/K+-ATPase pump, which moves potassium into cells along with glucose.</li>
  <li>This intracellular shift lowers the serum potassium level, potentially causing or worsening hypokalemia, especially in DKA treatment where total body potassium may already be depleted despite initial serum levels.</li>
  <li>Monitoring potassium levels frequently and administering potassium replacement as needed are critical nursing interventions during IV insulin therapy for DKA.</li>
</ul>`
  }
];
